MicrobiologybioRxiv
A mouse-adapted SARS-CoV-2 model for the evaluation of COVID-19 medical countermeasures
K. H. Dinnon, S. R. Leist, A. Schafer…·R. S. Baric
This paper develops a mouse-adapted SARS-CoV-2 model to evaluate medical countermeasures, showing age-related disease severity and the efficacy of IFN lambda-1a.
DOI 10.1038/s41586-020-2708-8